OA08915A - Procédé de synthèse industrielle de perindopril et de ses principaux intermédiaires de synthèse. - Google Patents

Procédé de synthèse industrielle de perindopril et de ses principaux intermédiaires de synthèse.

Info

Publication number
OA08915A
OA08915A OA59433A OA59433A OA08915A OA 08915 A OA08915 A OA 08915A OA 59433 A OA59433 A OA 59433A OA 59433 A OA59433 A OA 59433A OA 08915 A OA08915 A OA 08915A
Authority
OA
OAPI
Prior art keywords
synthesis
perindopril
industrial
main
alanine
Prior art date
Application number
OA59433A
Other languages
English (en)
French (fr)
Inventor
Vincent Michel
Baliarda Jean
Marchand Bernard
Remond Georges
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9354991&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=OA08915(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Adir filed Critical Adir
Publication of OA08915A publication Critical patent/OA08915A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/022Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
    • C07K5/0222Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Bending Of Plates, Rods, And Pipes (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
  • Casting Devices For Molds (AREA)
OA59433A 1987-09-17 1988-09-16 Procédé de synthèse industrielle de perindopril et de ses principaux intermédiaires de synthèse. OA08915A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8712896A FR2620709B1 (fr) 1987-09-17 1987-09-17 Procede de synthese industrielle du perindopril et de ses principaux intermediaires de synthese

Publications (1)

Publication Number Publication Date
OA08915A true OA08915A (fr) 1989-10-31

Family

ID=9354991

Family Applications (1)

Application Number Title Priority Date Filing Date
OA59433A OA08915A (fr) 1987-09-17 1988-09-16 Procédé de synthèse industrielle de perindopril et de ses principaux intermédiaires de synthèse.

Country Status (15)

Country Link
US (1) US4914214A (enExample)
EP (1) EP0308341B1 (enExample)
JP (1) JPH01110696A (enExample)
AT (1) ATE59047T1 (enExample)
CA (1) CA1336348C (enExample)
DE (1) DE3861275D1 (enExample)
DK (1) DK171470B1 (enExample)
ES (1) ES2019703B3 (enExample)
FR (1) FR2620709B1 (enExample)
GR (1) GR3001539T3 (enExample)
IE (1) IE61453B1 (enExample)
NZ (1) NZ226224A (enExample)
OA (1) OA08915A (enExample)
PT (1) PT88527B (enExample)
ZA (1) ZA886932B (enExample)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2620700B1 (fr) * 1987-09-17 1990-06-01 Adir Procede de synthese d'alpha amino acides n alkyles et leurs esters. application a la synthese de carboxyalkyl dipeptides
FR2620699B1 (fr) * 1987-09-17 1990-06-01 Adir Procede de synthese d'alpha amino acides n alkyles et de leurs esters. application a la synthese de carboxyalkyl dipeptides
US5212319A (en) * 1990-02-26 1993-05-18 Eli Lilly And Company Intermediates to 4-amino-hexahydrobenz[cd]indoles and processes therefor
FR2807037B1 (fr) * 2000-03-31 2002-05-10 Adir NOUVEAU PROCEDE DE SYNTHESE DES ESTERS DE LA N-[(s)-1- CARBOXYBUTYL]-(S)-ALANINE ET APPLICATION A LA SYNTHESE DU PERINDOPRIL
FR2807431B1 (fr) * 2000-04-06 2002-07-19 Adir Nouveau procede de synthese du perindopril et de ses sels pharmaceutiquement acceptables
FR2807430B1 (fr) * 2000-04-11 2002-05-17 Adir Nouveau procede de synthese des esters de la n-[(s)-1- carboxybutyl]-(s)-alanine et application a la synthese du perindopril
FR2811320B1 (fr) * 2000-07-06 2002-08-23 Adir Nouvelle forme cristalline alpha du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent
FR2811318B1 (fr) * 2000-07-06 2002-08-23 Adir Nouvelle forme cristalline gamma du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent
FR2811319B1 (fr) * 2000-07-06 2002-08-23 Adir Nouvelle forme cristalline beta du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent
AU2007203451B2 (en) * 2000-07-06 2010-09-02 Les Laboratoires Servier Pharmaceutical composition containing a crystalline form of perindopril tert-butylamine salt
FR2827860B1 (fr) * 2001-07-24 2004-12-10 Servier Lab Nouveau procede de synthese de derives de l'acide (2s, 3as, 7as)-1-[(s)-alanyl]-octahydro-1h-indole-2-carboxyline et application a la synthese du perindopril
AR036187A1 (es) * 2001-07-24 2004-08-18 Adir Un proceso para la preparacion de perindopril, compuestos analogos y sus sales, compuesto intermediario 2,5-dioxo-oxazolidina y proceso para preparar un intermediario
SI1333026T1 (sl) * 2002-01-30 2007-10-31 Servier Lab Postopek priprave perindoprila visoke äśistoäśe in intermediatov uporabnih v sintezi
JP2005519098A (ja) * 2002-03-01 2005-06-30 ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー 変形性関節症の治療方法
GB2395195A (en) * 2002-11-18 2004-05-19 Cipla Ltd Preparation of perindopril from carboxy-protected precursor, & perindopril monohydrates for use as angiotensin converting enzyme (ACE) inhibitors
WO2004065368A1 (ja) * 2003-01-21 2004-08-05 Ohara Chemical Industries, Ltd. トランドラプリル合成中間体の製造方法
ATE307801T1 (de) * 2003-02-28 2005-11-15 Servier Lab Verfahren zur synthese des (2s,3as,7as)- perhydroindol-2-carbonsäures und seiner estern, verwendung in der synthese von perindopril
ES2307923T3 (es) * 2003-02-28 2008-12-01 Les Laboratoires Servier S.A. Procedimiento de preparacion de perindopril y sales del mismo.
SI1403275T1 (sl) * 2003-02-28 2006-02-28 Servier Lab Nov postopek sinteze perindoprila in njegovih farmacevtsko sprejemljivih soli
GB0305066D0 (en) * 2003-03-06 2003-04-09 Ibm System and method for publish/subscribe messaging
DK1348684T3 (da) * 2003-04-09 2006-07-03 Servier Lab Fremgangsmåde til syntese af (2S)-indolin-2-carboxylsyre og anvendelse heraf til syntese af perindopril
WO2004099138A2 (en) * 2003-05-12 2004-11-18 Cipla Limited Process for the preparation of perindopril
SI21507A (sl) * 2003-05-16 2004-12-31 LEK farmacevtska dru�ba d.d. Postopek za pripravo spojin z ace inhibitornim delovanjem
CN100395235C (zh) * 2003-06-24 2008-06-18 瑟维尔实验室 培哚普利特丁胺的新晶形
ATE360638T1 (de) * 2003-06-30 2007-05-15 Servier Lab Verfahren für die synthese von perindopril und seiner pharmazeutisch geeigneten salze
JP4677611B2 (ja) * 2003-10-21 2011-04-27 レ ラボラトワール セルヴィエ 結晶ペリンドプリルエルブミンの新規な調製方法
US20050171165A1 (en) * 2003-11-12 2005-08-04 Bhirud Shekhar B. Process for the preparation of perindopril
SI1420028T1 (sl) 2003-11-19 2007-06-30 Servier Lab Postopek za sintezo perindoprila in njegovih farmacevtsko sprejemljivih soli
SI1422236T1 (sl) * 2003-11-19 2007-06-30 Servier Lab Postopek za sintezo perindoprila in njegovih farmacevtsko sprejemljivih soli
EP1420030A3 (fr) * 2003-12-10 2004-05-26 Les Laboratoires Servier Procédé de synthèse de dérivés de l'acide (2S, 3aS, 7aS) - 1 - [(S)-alanyl]-octahydro-1H-indole-2-carboxylique et application à la synthèse du perindopril
SI21703A (en) * 2004-01-14 2005-08-31 Lek Farmacevtska Druzba Dd Inclusion complexes of perindopril, procedure of their preparation, pharmaceutical compositions containing these complexes and their application in treatment of hypertensia
SI21704A (en) * 2004-01-14 2005-08-31 Lek Farmacevtska Druzba Dd New crystal form of perindopril, procedure of its preparation, pharmaceutical preparations containing this form and their application in treatment of hypertensia
HRP20161602T1 (hr) * 2004-03-29 2016-12-30 Les Laboratoires Servier Postupak priprave čvrstog farmaceutskog pripravka
GB2413128A (en) * 2004-04-13 2005-10-19 Neopharma Ltd Process for the preparation of perindopril
WO2005108365A1 (en) * 2004-05-07 2005-11-17 Glenmark Pharmaceuticals Limited Processes for the preparation of alpha polymorph of perindopril erbumine
US20050250706A1 (en) * 2004-05-07 2005-11-10 Glenmark Pharmaceuticals Limited Processes for the preparation of alpha polymorph of perindopril erbumine
SI21800A (sl) * 2004-05-14 2005-12-31 Krka, Tovarna Zdravil, D.D., Novo Mesto Nov postopek sinteze perindoprila
US20060178422A1 (en) * 2004-05-31 2006-08-10 Ashok Kumar Process for making (2S, 3aS, 7aS)-1-[(2S)-2-[[(1S)-1-(ethoxycarbonyl) butyl] amino]-1-oxopropyl] octahydro-1H-indole-2-carboxylic acid
SI21881A (sl) 2004-10-15 2006-04-30 Diagen, Smartno Pri Ljubljani, D.O.O. Nove kristalne oblike perindopril erbumin hidratov, postopek za njihovo pripravo in farmacevtske oblike, ki vsebujejo te spojine
JP4547245B2 (ja) * 2004-12-16 2010-09-22 株式会社パーマケム・アジア ペリンドプリルエルブミンのi型結晶、及びその製造方法
ES2255872B1 (es) * 2004-12-31 2007-08-16 Quimica Sintetica, S.A. Procedimiento para la preparacion de perindopril erbumina.
SI1679072T1 (sl) 2005-01-06 2009-02-28 Ipca Lab Ltd Postopek za sintezo derivatov (2S,3aS,7aS)-1-(S)-alanil-oktahidro-1H-indol-2-karboksilne kisline inuporaba v sintezi perindoprila
MY138209A (en) * 2005-03-11 2009-05-29 Servier Lab New (y) crystalline form of perindopril tert-butylamine salt, a process for its preparation and pharmaceutical compositions containing it.
RS51147B (sr) * 2005-03-14 2010-10-31 Les Laboratoires Servier Poboljšani postupak za prečišćavanje perindoprila
US7291745B2 (en) * 2005-03-21 2007-11-06 Glenmark Pharmaceuticals Limited Process for the preparation of perindopril
KR20080046630A (ko) * 2005-07-05 2008-05-27 씨아이피엘에이 엘티디. Ace 저해제 트란돌라프릴의 제조방법
SI1910287T1 (sl) * 2005-07-25 2012-09-28 Lek Pharmaceuticals D.D. Postopek za pripravo kristalnega perindoprila
US20070032661A1 (en) * 2005-08-03 2007-02-08 Glenmark Pharmaceuticals Limited Process for the preparation of intermediates of perindopril
EP1792896A1 (en) 2005-12-01 2007-06-06 KRKA, tovarna zdravil, d.d., Novo mesto Process for the preparation of perindopril and salts thereof
EP1815857A1 (en) 2006-02-02 2007-08-08 LEK Pharmaceuticals D.D. A pharmaceutical composition comprising perindopril
EA007988B1 (ru) * 2006-04-20 2007-02-27 ИСМАГИЛОВ, Искандар Халиуллович ξ-ЗЕТА ФОРМА ПЕРИНДОПРИЛ ЭРБУМИНА
EP1864973A1 (en) * 2006-06-09 2007-12-12 Sochinaz SA Process for the preparation of perindopril and salts thereof
EP2137148A1 (en) * 2007-03-22 2009-12-30 Aarti Healthcare Limited Process for the preparation of perindopril erbumine salt and novel polymorph (s) thereof
SI22543A (sl) 2007-06-27 2008-12-31 Krka, Tovarna Zdravil, D.D., Novo Mesto Nove soli perindoprila
CN101514180B (zh) * 2008-02-20 2012-08-01 上海医药工业研究院 培哚普利叔丁铵盐的ⅰ晶型及其制备方法
AU2009263737B2 (en) 2008-06-24 2013-10-24 Tianish Laboratories Private Limited Novel polymorphic forms of Perindopril (L)-Arginine and process for the preparation thereof
GB0910692D0 (en) 2009-06-20 2009-08-05 Teva Pharma Compound
SI23149A (sl) 2009-09-21 2011-03-31 Silverstone Pharma Nove benzatinske soli ACE inhibitorjev, postopek za njihovo pripravo in njihova uporaba za zdravljenje kardiovaskularnih bolezni
PT105315B (pt) 2010-09-29 2013-01-16 Inst Superior Tecnico Uma nova forma cristalina hidratada de erbumina de perindopril, métodos para a sua preparação e sua utilização em preparações farmacêuticas
FR2985512B1 (fr) * 2012-01-05 2014-06-20 Servier Lab Procede de preparation du sel de l-arginine du perindopril
WO2016178591A2 (en) 2015-05-05 2016-11-10 Gene Predit, Sa Genetic markers and treatment of male obesity
PH12018502155B1 (en) 2016-04-20 2024-03-27 Servier Lab Pharmaceutical composition comprising a beta blocker, a converting enzyme inhibitor and an antihypertensive or an nsaid
CN106631977A (zh) * 2016-11-11 2017-05-10 上海雅本化学有限公司 一种s‑吲哚啉‑2‑羧酸合成的优化方法
CN108752259A (zh) * 2018-07-04 2018-11-06 南京方生和医药科技有限公司 培哚普利消旋体及其中间体的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2503155A2 (fr) * 1980-10-02 1982-10-08 Science Union & Cie Nouveaux imino diacides substitues, leurs procedes de preparation et leur emploi comme inhibiteur d'enzyme
DE3360065D1 (en) * 1982-03-08 1985-03-28 Schering Corp Carboxyalkyl dipeptides, processes for their production and pharmaceutical compositions containing them
DE3302125A1 (de) * 1983-01-22 1984-07-26 Boehringer Ingelheim KG, 6507 Ingelheim Aminosaeure-derivate, verfahren zu ihrer herstellung und verwendung
DE3431541A1 (de) * 1984-08-28 1986-03-06 Hoechst Ag, 6230 Frankfurt Cis,endo-2-azabicycloalkan-3-carbonsaeure-derivate, verfahren zu deren herstellung, deren verwendung sowie zwischenprodukte bei deren herstellung

Also Published As

Publication number Publication date
ATE59047T1 (de) 1990-12-15
CA1336348C (fr) 1995-07-18
EP0308341B1 (fr) 1990-12-12
IE61453B1 (en) 1994-11-02
ES2019703B3 (es) 1991-07-01
NZ226224A (en) 1990-09-26
ZA886932B (en) 1989-05-30
IE882806L (en) 1989-03-17
JPH01110696A (ja) 1989-04-27
FR2620709A1 (fr) 1989-03-24
GR3001539T3 (en) 1992-11-23
EP0308341A1 (fr) 1989-03-22
US4914214A (en) 1990-04-03
DK515188A (da) 1989-03-18
PT88527B (pt) 1993-03-31
FR2620709B1 (fr) 1990-09-07
AU2236288A (en) 1989-03-23
DK515188D0 (da) 1988-09-15
JPH0543717B2 (enExample) 1993-07-02
AU608363B2 (en) 1991-03-28
PT88527A (pt) 1988-10-01
DE3861275D1 (de) 1991-01-24
DK171470B1 (da) 1996-11-11

Similar Documents

Publication Publication Date Title
OA08915A (fr) Procédé de synthèse industrielle de perindopril et de ses principaux intermédiaires de synthèse.
Tesser et al. The methylsulfonylethyloxycarbonyl group, a new and versatile amino protective function
Sanger The chemistry of insulin
Berg et al. Affinity column purification of protocollagen proline hydroxylase from chick embryos and further characterization of the enzyme
Kovacs et al. Polypeptides with Known Repeating Sequence of Amino Acids. Synthesis of Poly-L-glutamyl-L-alanyl-L-glutamic Acid and Polyglycylglycyl-L-phenylalanine through Pentachlorophenyl Active Ester1
ATE98376T1 (de) Synthetische htlv-iii-peptid-zusammensetzungen und ihre verwendung.
FI865313A0 (fi) Parannettu menetelmä ja peptidi AIDS-sukuisten tautien osoittamiseksi
CA2185326A1 (en) Inhibitors of the 26s proteolytic complex and the 20s proteasome contained therein
GB1359123A (en) Preparation of aspartyl amino-acid alkyl esters
Brew et al. The isolation and characterization of the tryptic, chymotryptic, peptic, and cyanogen bromide peptides from bovine α-lactalbumin
Barton et al. Reductive radical decarboxylation of amino-acids and peptides
Pederson et al. Subtilisin cleavage of bovine plasma albumin. Reversible association of the two primary fragments and their relation to the structure of the parent protein
Goldberger et al. NH2-terminal sequence analysis of pro-C4, the precursor of the fourth component of guinea pig complement.
DK52987A (da) Dna-fragmenter af humant papillomavirus og fremgangsmaade til in vitro diagnosticering af papillomavirusinfektioner
Lu et al. The primary structure of tubulin sequences of the carboxyl terminus and seven other cyanogen bromide peptides from the α-chain
Tamaki Studies on peptide antibiotic" gratisin".
Abe et al. Synthesis of cyclo-diglycyl-L-lysyl-diglycyl-L-lysyl and hydrolysis by trypsin
FR2408580A1 (fr) Compositions de polypeptides contenant la sequence l-arginine-l-lysine-(acide l-aspartique)-l-valine-l-tyrosine, leur procede d'obtention et compositions therapeutiques en comportant
Sierra et al. The stereochemistry of the β-hydroxyleucine unit of frangulanine
US3607859A (en) Furylacryloylgly-clycyl-l-leucinamide and relateo peptides and use thereof in spectrophotometric assay for neutral protease
FR2401134A1 (fr) Procede pour la preparation de thymosine a1 et d'un analogue
KURAHASHI Identity of Gramicidin S, J1 and J2
Edwards et al. The metabolism of 1-hydrazinophthalazine: the correct structure of the pseudo “N-acetyl-1-hydrazinophthalazine”
Harris et al. The subunit structure of thiolase
GB1411184A (en) Polypeptides process for preparing them and their use as polyvalent isoinhibitors